News

A True-Dose of pet meds

BY Michael Johnsen

ST. CHARLES, Mo. — With pharmacies looking to expand their business in pet prescriptions, pet supplements may no longer be such a dog of a category. At the very least, a significant position in pet supplements, along with shelf talkers, can raise awareness that pharmacies aren’t just for the two-legged anymore.


True-Dose features patented supplement solutions that are easier to administer to the family pet with a flavored, liquid formulation that can be added to either dry or wet food through a measured delivery device to provide precise dosing.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Tattoo aftercare, maintenance

BY Michael Johnsen

Tattoo Goo recently introduced an incremental traffic-driving opportunity with its body art aftercare kit of the same name. Tattoos no longer are taboo as more than 12 million adults sport permanent body art, including 25% of those between the ages of 30 and 39 years, and 12% of those between the ages of 40 and 49 years. 


Today’s aftercare protocol has the recently inked reaching for A+D ointment. But Tattoo Goo, which estimates the total market may exceed $100 million, fields not only its aftercare regimen but also a maintenance oil to prevent fading.

  

The article above is part of the DSN Category Review Series. For the complete First Aid Sell-Through Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Q&A: Prestige-ous plan

BY Michael Johnsen

Prestige Brands earlier this year completed its acquisition of 17 GlaxoSmithKline brands. Drug Store News sat with Prestige SVP sales and marketing Tim Connors to discuss what’s next.


DSN: What is the next step? 


Tim Connors: Our strategic value creation plan consists of three components: 


  1. Grow our brands organically; 

  2. Acquire [additional] OTC brands; and 

  3. Strategically manage our portfolio. 


That’s our roadmap to becoming a $1 billion OTC company.


DSN: What are some of the synergies that you see coming out of Prestige’s broader portfolio. 


Connors: The real benefit from having an expanded brand portfolio, simply put, [is] the shared knowledge across our brand portfolios in analgesics, gastrointestinal, cough-cold, ear-eye, oral care, sleep aids, dermatology and household. Developing and sharing consumer insights, new product development technologies, class of trade expertise and a deeper knowledge of the consumer are the most important building blocks for our brands long term. 


DSN: Can you provide an example?


Connors: Dramamine. … We [uncovered] a consumer insight that moms use the [adult] product for their kids. … So we came out with a new Dramamine for Kids with a lower dose that would be applicable for children under 13 [years of age]. 


keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES